Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Marck to introduce Paracetamol IV in plastic package in India
The company already exports the drug to West Africa, South East Asia and Middle East markets. Marck has obtained approvals for the product in Benin, Kenya, Yemen, Nigeria,
The company already exports the drug to West Africa, South East Asia and Middle East markets. Marck has obtained approvals for the product in Benin, Kenya, Yemen, Nigeria,
Vij worked as Group President -Defence in Punj Lloyd. Before joining Punj Lloyd, Vij has worked with General Motors for 18 years and has held key leadership positions
LIOVEL is a combined fixed dose tablet of NESINA and ACTOS. NESINA (alogliptin) and Actos (pioglitazone Hcl) are indicated for a treatment of type 2 diabetes. LIOVEL is
As per the terms of the agreement, OctoPlus will act as a process development and manufacturing partner for microsphere-based formulation for the Danish pharma firm. OctoPlus is a
Most recently, Zerhouni was serving as the acting president and CEO of the Diamyd Medical since April 201, though he has been involved in all aspects of the
The study namely BOLERO-2 (Breast cancer trials of OraL EveROlimus-2) involved around 700 patients at over 195 sites worldwide. The study included postmenopausal women with ER+HER2- metastatic breast
A wholly subsidiary of Fresenius Kabi Pharmaceuticals, APP Pharma expects to launch extended product line of its current portfolio in next few months. The company will market Levothyroxine
With this acquisition, Swisher Hygiene will use Sanolite’s headquarters to operate its chemical business in the Northeast region. The new regional operating structure allows for more efficient distribution
Chantix is a non-nicotine prescription medicine to help adults 18 and over stop smoking. Pfizer said results from 14 clinical trials involving approximately 7,000 smokers played vital role
Following the completion of an ongoing open-label Phase 1b clinical trial, the company intends to start INNO-206 Phase 2b trial with late-stage soft tissue sarcomas in the second